Clinical trial
HORIZON-PFT: Pivotal Fracture Trial
NCT00049829 is registered in ClinicalTrials.gov with Novartis Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- HORIZON-PFT: Pivotal Fracture Trial
- Lead sponsor
- Novartis Pharmaceuticals
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 31, 2002
- Completion date
- Not reported
- Enrollment
- 7,700
- Sites
- 60
Conditions
As the registry lists them; a condition with its own page is linked.